SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-19-012431
Filing Date
2019-11-07
Accepted
2019-11-06 19:57:45
Documents
59
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT vtgn10q_sep302019.htm 10-Q 1672542
2 FORM OF SUBSCRIPTION AGREEMENT FOR FALL 2019 PRIVATE PLACEMENT ex10-1.htm EX-10.1 109855
3 FORM OF WARRANT FOR FALL 2019 PRIVATE PLACEMENT ex10-2.htm EX-10 51223
4 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF ex31-1.htm EX-31 12216
5 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF ex31-2.htm EX-31.2 12444
6 CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE ex32.htm EX-32 7329
  Complete submission text file 0001654954-19-012431.txt   3833911

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT vtgn-20190930.xml EX-101.INS 429197
8 XBRL TAXONOMY EXTENSION SCHEMA vtgn-20190930.xsd EX-101.SCH 28725
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vtgn-20190930_cal.xml EX-101.CAL 41398
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vtgn-20190930_def.xml EX-101.DEF 86057
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE vtgn-20190930_lab.xml EX-101.LAB 189987
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vtgn-20190930_pre.xml EX-101.PRE 160138
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-577-3600
VistaGen Therapeutics, Inc. (Filer) CIK: 0001411685 (see all company filings)

IRS No.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-37761 | Film No.: 191197790
SIC: 2834 Pharmaceutical Preparations